CDRE | Cadre HoldingsNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$31.06
-$0.45 (-1.43%)

Cadre Holdings (CDRE) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, below both on the weekly and above both on the 4-hour. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $31.06 vs 50 $27.86 / 200 $32.10
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Apr 2026 ยท projected 27 bars out

Cross history

24
crosses on record since 2022
12 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
21 Sep 2026Death4-hour27 bars outNot tested
6 Aug 2026Golden4-hour11 bars outNot tested
15 Apr 2026Death steepdaily27 bars outNot tested
12 Mar 2026Death4-hour4 bars outNot tested
15 Oct 2025Golden moderatedaily29 bars outNot tested

About CDRE

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$12.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.